Krystal Biotech, Inc. (KRYS) › Capital ExpendituresKrystal Biotech, Inc. (KRYS) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2016: $15.0K2017: $210.0K2018: $2.23M2019: $6.40M2020: $14.84M2021: $68.34M2022: $52.98M2023: $11.80M2024: $4.24M2025: $11.95M$11.95M2016Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$11.95M+182.0%2024$4.24M-64.1%2023$11.80M-77.7%2022$52.98M-22.5%2021$68.34M+360.4%2020$14.84M+132.0%2019$6.40M+186.4%2018$2.23M+963.8%2017$210.0K+1300.0%2016$15.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share